The Use of Aspirin to Reduce the Risk of Thrombotic Events in Patients With End-Stage Renal Disease: Protocol for a Randomized Controlled Trial

The Use of Aspirin to Reduce the Risk of Thrombotic Events in Patients With End-Stage Renal Disease: Protocol for a Randomized Controlled Trial

Authors of this article:

Tiago Lemos Cerqueira^{1, 2, 3} ;   Armando Fartolino Guerrero^{2, 4} ;   Clara Krystal Pérez Fermin^{2, 5} ;   Ricardo Wang^{2, 6} ;   Evelin Elfriede Balbino^{2, 7} ;   Janis L Breeze^{8, 9} ;   Paola Gonzalez Mego^{2, 10} ;   Daniele Argentina Silva^{2, 11} ;   Walid Ezzeldin Omer^{2, 12} ;   Nathalie Monique Vandevelde^{2, 13}